IP/14/2634  15-12-2014 - EU backs 328 top early-career researchers with €485 million 
European Commission - European Commission - Press release Brussels, 15 December 2014 The European Research Council (ERC) has selected 328 first class scientists to receive its prestigious Starting Grants, worth up to €2 million each. The awarded €485 million contributes to supporting a new generation of top scientists in Europe developing so-called "blue...
IP/14/2383  05-12-2014 - Switzerland and EU join forces in science and research 
European Commission - European Commission - Press release Brussels, 05 December 2014 The European Union and Switzerland are today (5 December 2014) signing a comprehensive international agreement associating Switzerland to parts of Horizon 2020, Research and Training Programme of Euratom and the ITER project.
IP/14/2342  04-12-2014 - EU companies must boost R&D investment to stay globally competitive 
European Commission - European Commission - Press release Brussels, 04 December 2014 Investment in research and development by companies based in the EU grew by 2.6% in 2013, despite the unfavourable economic environment. However, this growth has slowed in comparison to the previous year's 6.8%.
MEMO/14/2347  04-12-2014 - World trends in R&D private investment. Facts and figures 
European Commission - European Commission - Fact Sheet Brussels, 04 December 2014 The European Commission published today its 2014 EU Industrial R&D Investment Scoreboard. The Scoreboard is based on a sample of 2500 companies, the world's top investors in Research and Development (R&D) and equivalent to about 90% of the total expenditure on...
IP/14/2273  02-12-2014 - Europe and Africa double research efforts to tackle AIDS, Ebola and other infectious diseases 
European Commission - European Commission - Press release 02 December 2014 Cape Town, South Africa The EU and Africa are today doubling the research efforts to develop new and better medicines for poverty-related diseases affecting sub-Saharan Africa such as AIDS, tuberculosis, malaria, hookworms and Ebola.
SPEECH/14/1887  17-11-2014 - Three pillars of disruptive innovation for Europe 
European Commission - European Commission - Speech - [Check Against Delivery] 17 November 2014 Carlos Moedas - Commissioner for Research, Science and Innovation Brussels, European Parliament, 6th European Innovation Summit   Vice Chair and Honourable Member President Buzek, Honourable Member Van Nistelrooij, Commissioner Crețu, Commissioner Hogan, Commissioner Bieńkowska, esteemed guests, Ladies and gentlemen,...
SPEECH/14/1765  14-11-2014 - Talent, commitment and resourcefulness in the pursuit of excellence in Europe 
European Commission - European Commission - Speech - [Check Against Delivery] 14 November 2014 Carlos Moedas - Commissioner for Research, Science and Innovation Kaunas, Lithuania Rector, Prime Minister, Minister Pavalkis, Minister Gustas, Director, Mayor, Most Reverend Excellency, Ladies and Gentlemen, good morning.
IP/14/1462  06-11-2014 - Ebola response: EU scales up aid with planes, material aid and research support 
European Commission - European Commission - Press release Brussels, 06 November 2014 The European Union and its Member States have now pledged more than €1 billion in response to the Ebola crisis in West Africa. This means the Union has already gone beyond the target set by the European Council on 24 October...
IP/14/1211  28-10-2014 - Meet Poppy, the open-source, 3D-printed robot set to inspire innovation in classrooms 
European Commission - European Commission Press release Brussels, 28 October 2014 Meet Poppy, the first completely open-source, 3D printed, humanoid robot (@poppy_project). Poppy is a robot that anybody can build and program. That means it's not just a tool for scientists and engineers: the team of developers aims to make it part of...
IP/14/1198  27-10-2014 - EU breast cancer research targets personalised treatment 
European Commission - European Commission Press release Brussels, 27 October 2014 Caption: The ASSURE project tailors breast cancer screening – hematoxylin and eosin marked breast tissue containing invasive ductal carcinoma. Copyright: ©VPH-PRISM Today, in most developed countries, one in eight women will likely develop breast cancer during their lifetime.